{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T02:00:10Z","timestamp":1791165610887,"version":"4.1.0"},"reference-count":208,"publisher":"IMR Press","issue":"9","license":[{"start":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T00:00:00Z","timestamp":1663113600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Cardiovasc. Med."],"abstract":"<jats:p>Background: The atherosclerotic cardiovascular disease (ASCVD) is a major killer and health care burden worldwide. Atherosclerosis, the common pathological foundation, has been associated with inflammation over the past few years. Some promising results also have emerged suggesting the role of targeting inflammation as a potential therapeutic option to reduce cardiovascular events. In light of the pathogenic role that inflammation plays in ASCVD, we propose to evaluate the worldwide research architecture for ASCVD and inflammation using bibliometric analysis. Methods: A search of the Web of Science Core Collection of Clarivate Analytics was performed for articles in the field published between 2012 and 2022. The number of publications per year has been visualized using GraphPad Prism through time. CiteSpace and VOSviewer were used to generate knowledge maps about the collaboration of countries, institutions, and authors, and to represent the landscape on ASCVD and inflammation research as well as to reveal current foci. Results: There were a total of 19,053 publications examined in this study. The most publications came from China (6232, 32.71%). Capital Med Univ was the most productive institution (410, 2.15%). Christian Weber published the greatest number of articles (75, 0.39%). PloS one was identified as the most prolific journal (706, 3.71%). Circulation was the most co-cited journal (13276, 2.81%). Keywords with the ongoing strong citation bursts were \u201cnucleotide-binding oligomerization (NOD), Leucine-rich repeat (LRR)-containing protein (NLRP3) inflammasome\u201d, \u201cintestinal microbiota\u201d, \u201cexosome\u201d, \u201clncRNAs\u201d, etc. Conclusions: It can be shown that ASCVD and inflammation research benefited from manuscripts that had a high impact on the scientific community. Asian, European and North American countries dominated in the field in terms of quantitative, qualitative and collaborative parameters. The NLRP3 inflammasome, gut microbiota and trimethylamine N-oxide, autophagy, lncRNAs, exosomes, and nuclear factor erythroid 2-related factor 2 were described to be hot themes in the field.<\/jats:p>","DOI":"10.31083\/j.rcm2309317","type":"journal-article","created":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T07:53:06Z","timestamp":1663314786000},"source":"Crossref","is-referenced-by-count":7,"title":["Research Landscape on Atherosclerotic Cardiovascular Disease and Inflammation: A Bibliometric and Visualized Study"],"prefix":"10.31083","volume":"23","author":[{"given":"Wende","family":"Tian","sequence":"first","affiliation":[{"name":"Xiyuan Hospital, China Academy of Chinese Medical Sciences, 100091 Beijing, China"},{"name":"Graduate School, China Academy of Chinese Medical Sciences, 100700 Beijing, China"},{"name":"National Clinical Research Center for Chinese Medicine Cardiology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, 100091 Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tai","family":"Zhang","sequence":"first","affiliation":[{"name":"Xiyuan Hospital, China Academy of Chinese Medical Sciences, 100091 Beijing, China"},{"name":"Graduate School, China Academy of Chinese Medical Sciences, 100700 Beijing, China"},{"name":"Department of Gastroenterology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, 100091 Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Wang","sequence":"first","affiliation":[{"name":"Xiyuan Hospital, China Academy of Chinese Medical Sciences, 100091 Beijing, China"},{"name":"Graduate School, China Academy of Chinese Medical Sciences, 100700 Beijing, China"},{"name":"National Clinical Research Center for Chinese Medicine Cardiology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, 100091 Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhang","sequence":"first","affiliation":[{"name":"National Clinical Research Center for Chinese Medicine Cardiology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, 100091 Beijing, China"},{"name":"Graduate School, Beijing University of Chinese Medicine, 100029 Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianqing","family":"Ju","sequence":"first","affiliation":[{"name":"Xiyuan Hospital, China Academy of Chinese Medical Sciences, 100091 Beijing, China"},{"name":"National Clinical Research Center for Chinese Medicine Cardiology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, 100091 Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Xu","sequence":"first","affiliation":[{"name":"Xiyuan Hospital, China Academy of Chinese Medical Sciences, 100091 Beijing, China"},{"name":"National Clinical Research Center for Chinese Medicine Cardiology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, 100091 Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"16242","published-online":{"date-parts":[[2022,9,14]]},"reference":[{"key":"ref1","unstructured":"Authors\/Task Force Members, Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts): Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). European Journal of Preventive Cardiology. 2016; 23: NP1\u2013NP96."},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Sanchis-Gomar F, Perez-Quilis C, Leischik R, Lucia A. Epidemiology of coronary heart disease and acute coronary syndrome. Annals of Translational Medicine. 2016; 4: 256.","DOI":"10.21037\/atm.2016.06.33"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Hess CN, Clare RM, Neely ML, Tricoci P, Mahaffey KW, James SK, et al. Differential occurrence, profile, and impact of first recurrent cardiovascular events after an acute coronary syndrome. American Heart Journal. 2017; 187: 194\u2013203.","DOI":"10.1016\/j.ahj.2017.01.016"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Jernberg T, Hasvold P, Henriksson M, Hjelm H, Thuresson M, Janzon M. Cardiovascular risk in post-myocardial infarction patients: nationwide real world data demonstrate the importance of a long-term perspective. European Heart Journal. 2015; 36: 1163\u20131170.","DOI":"10.1093\/eurheartj\/ehu505"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Catapano AL, Graham I, De Backer G, Wiklund O, Chapman MJ, Drexel H, et al. 2016 ESC\/EAS Guidelines for the Management of Dyslipidaemias. European Heart Journal. 2016; 37: 2999\u20133058.","DOI":"10.1093\/eurheartj\/ehw272"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Motivala AA, Tamhane U, Ramanath VS, Saab F, Montgomery DG, Fang J, et al. A Prior Myocardial Infarction: how does it Affect Management and Outcomes in Recurrent Acute Coronary Syndromes? Clinical Cardiology. 2008; 31: 590\u2013596.","DOI":"10.1002\/clc.20356"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, et al. 2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ ASPC\/NLA\/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Journal of the American College of Cardiology. 2019; 73: e285\u2013e350. Erratum in: Journal of the American College of Cardiology. 2019; 73: 3237\u20133241.","DOI":"10.1016\/j.jacc.2018.11.004"},{"key":"ref8","unstructured":"Murphy SL, Xu J, Kochanek KD, Curtin SC, Arias E. Deaths: Final Data for 2015. National Vital Statistics Reports. 2017; 66: 1\u201375."},{"key":"ref9","unstructured":"GBD 2017 Causes of Death Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018; 392: 1736\u20131788. Erratum in: Lancet. 2019; 393:e44. Erratum in: Lancet. 2018; 392: 2170."},{"key":"ref10","unstructured":"Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, et al. 2019 ACC\/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019; 140: e596\u2013e646. Erratum in: Circulation. 2019; 140: e649\u2013e650. Erratum in: Circulation. 202; 141: e60. Erratum in: Circulation. 2020; 141: e774."},{"key":"ref11","unstructured":"Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, et al. Heart disease and stroke statistics\u20132012 update: a report from the American Heart Association. Circulation. 2012; 125: e2\u2013e220."},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Perel P, Avezum A, Huffman M, Pais P, Rodgers A, Vedanthan R, et al. Reducing Premature Cardiovascular Morbidity and Mortality in People With Atherosclerotic Vascular Disease: The World Heart Federation Roadmap for Secondary Prevention of Cardiovascular Disease. Global Heart. 2015; 10: 99\u2013110. Erratum in: Global Heart. 2015; 10: 225. Vedanthan, Raj [corrected to Vedanthan, Rajesh].","DOI":"10.1016\/j.gheart.2015.04.003"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLOS Medicine. 2006; 3: e442.","DOI":"10.1371\/journal.pmed.0030442"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Medzhitov R. Origin and physiological roles of inflammation. Nature. 2008; 454: 428\u2013435.","DOI":"10.1038\/nature07201"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Viola J, Soehnlein O. Atherosclerosis \u2013 a matter of unresolved inflammation. Seminars in Immunology. 2015; 27: 184\u2013193.","DOI":"10.1016\/j.smim.2015.03.013"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Vance D. Cholesterol in the year 2000. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 2000; 1529: 1\u20138.","DOI":"10.1016\/S1388-1981(00)00133-5"},{"key":"ref17","unstructured":"Hodgson JA. Treatise on the Diseases of Arteries and Veins. Thomas Underwood: London, UK. 1815."},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Virchow R. Cellular pathology. As based upon physiological and pathological histology. Lecture XVI\u2013Atheromatous affection of arteries. 1858. Nutrition Reviews. 1989; 47: 23\u201325.","DOI":"10.1111\/j.1753-4887.1989.tb02747.x"},{"key":"ref19","unstructured":"Osler W. Diseases of the arteries. In Osler W (ed.) Modern Medicine: Its Practice and Theory (pp. 429\u2013447.). Lea and Febiger: Philadelphia, PA. 1908."},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Ross R. Atherosclerosis \u2014 an Inflammatory Disease. New England Journal of Medicine. 1999; 340: 115\u2013126.","DOI":"10.1056\/NEJM199901143400207"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Kattoor AJ, Pothineni NVK, Palagiri D, Mehta JL. Oxidative Stress in Atherosclerosis. Current Atherosclerosis Reports. 2017; 19: 42.","DOI":"10.1007\/s11883-017-0678-6"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Williams KJ, Tabas I. The Response-to-Retention Hypothesis of Early Atherogenesis. Arteriosclerosis, Thrombosis, and Vascular Biology. 1995; 15: 551\u2013561.","DOI":"10.1161\/01.ATV.15.5.551"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Krystel-Whittemore M, Dileepan KN, Wood JG. Mast Cell: A Multi-Functional Master Cell. Frontiers in Immunology. 2016; 6: 620.","DOI":"10.3389\/fimmu.2015.00620"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Tabas I, Lichtman AH. Monocyte-Macrophages and T Cells in Atherosclerosis. Immunity. 2017; 47: 621\u2013634.","DOI":"10.1016\/j.immuni.2017.09.008"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Kojima Y, Weissman IL, Leeper NJ. The Role of Efferocytosis in Atherosclerosis. Circulation. 2017; 135: 476\u2013489.","DOI":"10.1161\/CIRCULATIONAHA.116.025684"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arteriosclerosis, Thrombosis, and Vascular Biology. 2000; 20: 1262\u20131275.","DOI":"10.1161\/01.ATV.20.5.1262"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Kubo T, Imanishi T, Takarada S, Kuroi A, Ueno S, Yamano T, et al. Assessment of culprit lesion morphology in acute myocardial infarction: ability of optical coherence tomography compared with intravascular ultrasound and coronary angioscopy. Journal of the American College of Cardiology. 2007; 50: 933\u2013939.","DOI":"10.1016\/j.jacc.2007.04.082"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J, et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation. 2003; 108: 1664\u20131672.","DOI":"10.1161\/01.CIR.0000087480.94275.97"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"van der Wal AC, Becker AE, van der Loos CM, Das PK. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation. 1994; 89: 36\u201344.","DOI":"10.1161\/01.CIR.89.1.36"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Tang D, Teng Z, Canton G, Hatsukami TS, Dong L, Huang X, et al. Local critical stress correlates better than global maximum stress with plaque morphological features linked to atherosclerotic plaque vulnerability: an in vivo multi-patient study. BioMedical Engineering OnLine. 2009; 8: 15.","DOI":"10.1186\/1475-925X-8-15"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Slager C, Wentzel J, Gijsen F, Schuurbiers J, van der Wal A, van der Steen A, et al. The role of shear stress in the generation of rupture-prone vulnerable plaques. Nature Clinical Practice Cardiovascular Medicine. 2005; 2: 401\u2013407.","DOI":"10.1038\/ncpcardio0274"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Burke AP, Farb A, Malcom GT, Liang Y, Smialek J, Virmani R. Coronary Risk Factors and Plaque Morphology in Men with Coronary Disease who Died Suddenly. New England Journal of Medicine. 1997; 336: 1276\u20131282.","DOI":"10.1056\/NEJM199705013361802"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Kolodgie FD, Burke AP, Farb A, Gold HK, Yuan J, Narula J, et al. The thin-cap fibroatheroma: a type of vulnerable plaque: the major precursor lesion to acute coronary syndromes. Current Opinion in Cardiology. 2001; 16: 285\u2013292.","DOI":"10.1097\/00001573-200109000-00006"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Bentzon JF, Otsuka F, Virmani R, Falk E. Mechanisms of plaque formation and rupture. Circulation Research. 2014; 114: 1852\u20131866.","DOI":"10.1161\/CIRCRESAHA.114.302721"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Flego D, Liuzzo G, Weyand CM, Crea F. Adaptive Immunity Dysregulation in Acute Coronary Syndromes: From Cellular and Molecular Basis to Clinical Implications. Journal of the American College of Cardiology. 2016; 68: 2107\u20132117.","DOI":"10.1016\/j.jacc.2016.08.036"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Amento EP, Ehsani N, Palmer H, Libby P. Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells. Arteriosclerosis and Thrombosis: a Journal of Vascular Biology. 1991; 11: 1223\u20131230.","DOI":"10.1161\/01.ATV.11.5.1223"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"Ovchinnikova OA, Folkersen L, Persson J, Lindeman JHN, Ueland T, Aukrust P, et al. The collagen cross-linking enzyme lysyl oxidase is associated with the healing of human atherosclerotic lesions. Journal of Internal Medicine. 2014; 276: 525\u2013536.","DOI":"10.1111\/joim.12228"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Hansson GK, Hellstrand M, Rymo L, Rubbia L, Gabbiani G. Interferon gamma inhibits both proliferation and expression of differentiation-specific alpha-smooth muscle actin in arterial smooth muscle cells. Journal of Experimental Medicine. 1989; 170: 1595\u20131608.","DOI":"10.1084\/jem.170.5.1595"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Ovchinnikova O, Robertson AK, W\u00e5gs\u00e4ter D, Folco EJ, Hyry M, Myllyharju J, et al. T-cell activation leads to reduced collagen maturation in atherosclerotic plaques of Apoe(-\/-) mice. The American Journal of Pathology. 2009; 174: 693\u2013700.","DOI":"10.2353\/ajpath.2009.080561"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"B\u00e4ck M, Ketelhuth DFJ, Agewall S. Matrix Metalloproteinases in Atherothrombosis. Progress in Cardiovascular Diseases. 2010; 52: 410\u2013428.","DOI":"10.1016\/j.pcad.2009.12.002"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"Ait-Oufella H, Taleb S, Mallat Z, Tedgui A. Recent Advances on the Role of Cytokines in Atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology. 2011; 31: 969\u2013979.","DOI":"10.1161\/ATVBAHA.110.207415"},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"Kovanen PT, Kaartinen M, Paavonen T. Infiltrates of Activated Mast Cells at the Site of Coronary Atheromatous Erosion or Rupture in Myocardial Infarction. Circulation. 1995; 92: 1084\u20131088.","DOI":"10.1161\/01.CIR.92.5.1084"},{"key":"ref43","doi-asserted-by":"crossref","unstructured":"Hansson GK. Inflammation, Atherosclerosis, and Coronary Artery Disease. New England Journal of Medicine. 2005; 352: 1685\u20131695.","DOI":"10.1056\/NEJMra043430"},{"key":"ref44","doi-asserted-by":"crossref","unstructured":"Badimon L, Padr\u00f3 T, Vilahur G. Atherosclerosis, platelets and thrombosis in acute ischaemic heart disease. European Heart Journal: Acute Cardiovascular Care. 2012; 1: 60\u201374.","DOI":"10.1177\/2048872612441582"},{"key":"ref45","doi-asserted-by":"crossref","unstructured":"Fazio GP, Redberg RF, Winslow T, Schiller NB. Transesophageal echocardiographically detected atherosclerotic aortic plaque is a marker for coronary artery disease. Journal of the American College of Cardiology. 1993; 21: 144\u2013150.","DOI":"10.1016\/0735-1097(93)90729-K"},{"key":"ref46","doi-asserted-by":"crossref","unstructured":"Libby P, Pasterkamp G. Requiem for the \u2018vulnerable plaque\u2019. European Heart Journal. 2015; 36: 2984\u20132987.","DOI":"10.1093\/eurheartj\/ehv349"},{"key":"ref47","doi-asserted-by":"crossref","unstructured":"Pasterkamp G, den Ruijter HM, Libby P. Temporal shifts in clinical presentation and underlying mechanisms of atherosclerotic disease. Nature Reviews Cardiology. 2017; 14: 21\u201329.","DOI":"10.1038\/nrcardio.2016.166"},{"key":"ref48","doi-asserted-by":"crossref","unstructured":"Kramer MCA, Rittersma SZH, de Winter RJ, Ladich ER, Fowler DR, Liang Y, et al. Relationship of Thrombus Healing to Underlying Plaque Morphology in Sudden Coronary Death. Journal of the American College of Cardiology. 2010; 55: 122\u2013132.","DOI":"10.1016\/j.jacc.2009.09.007"},{"key":"ref49","doi-asserted-by":"crossref","unstructured":"Campbell IC, Suever JD, Timmins LH, Veneziani A, Vito RP, Virmani R, Oshinski JN, Taylor WR. Biomechanics and inflammation in atherosclerotic plaque erosion and plaque rupture: implications for cardiovascular events in women. PLoS ONE. 2014; 9: e111785.","DOI":"10.1371\/journal.pone.0111785"},{"key":"ref50","doi-asserted-by":"crossref","unstructured":"Newby AC, Johnson TW, White SJ. Endothelial erosion of plaques as a substrate for coronary thrombosis. Thrombosis and Haemostasis. 2016; 115: 509\u2013519.","DOI":"10.1160\/th15-09-0765"},{"key":"ref51","doi-asserted-by":"crossref","unstructured":"Quillard T, Ara\u00fajo HA, Franck G, Shvartz E, Sukhova G, Libby P. TLR2 and neutrophils potentiate endothelial stress, apoptosis and detachment: implications for superficial erosion. European Heart Journal. 2015; 36: 1394\u20131404.","DOI":"10.1093\/eurheartj\/ehv044"},{"key":"ref52","doi-asserted-by":"crossref","unstructured":"Franck G, Mawson T, Sausen G, Salinas M, Masson GS, Cole A, et al. Flow Perturbation Mediates Neutrophil Recruitment and Potentiates Endothelial Injury via TLR2 in Mice. Circulation Research. 2017; 121: 31\u201342.","DOI":"10.1161\/CIRCRESAHA.117.310694"},{"key":"ref53","doi-asserted-by":"crossref","unstructured":"Moschonas IC, Tselepis AD. The pathway of neutrophil extracellular traps towards atherosclerosis and thrombosis. Atherosclerosis. 2019; 288: 9\u201316.","DOI":"10.1016\/j.atherosclerosis.2019.06.919"},{"key":"ref54","doi-asserted-by":"crossref","unstructured":"Gimbrone MA, Garc\u00eda-Carde\u00f1a G. Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis. Circulation Research. 2016; 118: 620\u2013636.","DOI":"10.1161\/CIRCRESAHA.115.306301"},{"key":"ref55","doi-asserted-by":"crossref","unstructured":"Leistner DM, Kr\u00e4nkel N, Meteva D, Abdelwahed YS, Seppelt C, St\u00e4hli BE, et al. Differential immunological signature at the culprit site distinguishes acute coronary syndrome with intact from acute coronary syndrome with ruptured fibrous cap: results from the prospective translational OPTICO-ACS study. European Heart Journal. 2020; 41: 3549\u20133560.","DOI":"10.1093\/eurheartj\/ehaa703"},{"key":"ref56","doi-asserted-by":"crossref","unstructured":"Pedicino D, Vinci R, Giglio AF, Pisano E, Porto I, Vergallo R, et al. Alterations of Hyaluronan Metabolism in Acute Coronary Syndrome: Implications for Plaque Erosion. Journal of the American College of Cardiology. 2018; 72: 1490\u20131503.","DOI":"10.1016\/j.jacc.2018.06.072"},{"key":"ref57","doi-asserted-by":"crossref","unstructured":"Sato Y. Proportion of fibrin and platelets differs in thrombi on ruptured and eroded coronary atherosclerotic plaques in humans. Heart. 2005; 91: 526\u2013530.","DOI":"10.1136\/hrt.2004.034058"},{"key":"ref58","doi-asserted-by":"crossref","unstructured":"Libby P, Pasterkamp G, Crea F, Jang I. Reassessing the Mechanisms of Acute Coronary Syndromes. Circulation Research. 2019; 124: 150\u2013160.","DOI":"10.1161\/CIRCRESAHA.118.311098"},{"key":"ref59","doi-asserted-by":"crossref","unstructured":"Libby P. Superficial erosion and the precision management of acute coronary syndromes: not one-size-fits-all. European Heart Journal. 2017; 38: 801\u2013803.","DOI":"10.1093\/eurheartj\/ehw599"},{"key":"ref60","doi-asserted-by":"crossref","unstructured":"Jia H, Dai J, Hou J, Xing L, Ma L, Liu H, et al. Effective anti-thrombotic therapy without stenting: intravascular optical coherence tomography-based management in plaque erosion (the EROSION study). European Heart Journal. 2017; 38: 792\u2013800.","DOI":"10.1093\/eurheartj\/ehw381"},{"key":"ref61","doi-asserted-by":"crossref","unstructured":"Xing L, Yamamoto E, Sugiyama T, Jia H, Ma L, Hu S, et al. EROSION Study (Effective Anti-Thrombotic Therapy without Stenting: Intravascular Optical Coherence Tomography\u2013Based Management in Plaque Erosion). Circulation: Cardiovascular Interventions. 2017; 10: e005860","DOI":"10.1161\/CIRCINTERVENTIONS.117.005860"},{"key":"ref62","doi-asserted-by":"crossref","unstructured":"Fracassi F, Crea F, Sugiyama T, Yamamoto E, Uemura S, Vergallo R, et al. Healed Culprit Plaques in Patients with Acute Coronary Syndromes. Journal of the American College of Cardiology. 2019; 73: 2253\u20132263.","DOI":"10.1016\/j.jacc.2018.10.093"},{"key":"ref63","doi-asserted-by":"crossref","unstructured":"Meteva D, Seppelt C, Abdelwahed YS, Leistner DM. Distinct pathological mechanisms distinguish acute coronary syndrome caused by plaque erosion from plaque rupture. Current Opinion in Cardiology. 2021; 36: 793\u2013797.","DOI":"10.1097\/HCO.0000000000000912"},{"key":"ref64","doi-asserted-by":"crossref","unstructured":"Libby P, Tabas I, Fredman G, Fisher EA. Inflammation and its Resolution as Determinants of Acute Coronary Syndromes. Circulation Research. 2014; 114: 1867\u20131879.","DOI":"10.1161\/CIRCRESAHA.114.302699"},{"key":"ref65","doi-asserted-by":"crossref","unstructured":"Ridker PM. Residual inflammatory risk: addressing the obverse side of the atherosclerosis prevention coin. European Heart Journal. 2016; 37: 1720\u20131722.","DOI":"10.1093\/eurheartj\/ehw024"},{"key":"ref66","doi-asserted-by":"crossref","unstructured":"Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, et al. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease. New England Journal of Medicine. 2017; 377: 1119\u20131131.","DOI":"10.1056\/NEJMoa1707914"},{"key":"ref67","doi-asserted-by":"crossref","unstructured":"Tardif J, Kouz S, Waters DD, Bertrand OF, Diaz R, Maggioni AP, et al. Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction. New England Journal of Medicine. 2019; 381: 2497\u20132505.","DOI":"10.1056\/NEJMoa1912388"},{"key":"ref68","doi-asserted-by":"crossref","unstructured":"Nidorf SM, Fiolet ATL, Mosterd A, Eikelboom JW, Schut A, Opstal TSJ, et al. Colchicine in Patients with Chronic Coronary Disease. New England Journal of Medicine. 2020; 383: 1838\u20131847.","DOI":"10.1056\/NEJMoa2021372"},{"key":"ref69","doi-asserted-by":"crossref","unstructured":"Ridker PM, MacFadyen JG, Everett BM, Libby P, Thuren T, Glynn RJ, et al. Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial. Lancet. 2018; 391: 319\u2013328.","DOI":"10.1016\/S0140-6736(17)32814-3"},{"key":"ref70","doi-asserted-by":"crossref","unstructured":"Nidorf SM, Eikelboom JW, Budgeon CA, Thompson PL. Low-Dose Colchicine for Secondary Prevention of Cardiovascular Disease. Journal of the American College of Cardiology. 2013; 61: 404\u2013410.","DOI":"10.1016\/j.jacc.2012.10.027"},{"key":"ref71","doi-asserted-by":"crossref","unstructured":"Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, B\u00e4ck M, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. European Heart Journal. 2021; 42: 3227\u20133337.","DOI":"10.1093\/eurheartj\/ehab484"},{"key":"ref72","doi-asserted-by":"crossref","unstructured":"Libby P, Ridker PM, Maseri A. Inflammation and Atherosclerosis. Circulation. 2002; 105: 1135\u20131143.","DOI":"10.1161\/hc0902.104353"},{"key":"ref73","doi-asserted-by":"crossref","unstructured":"Brevetti G, Schiano V, Chiariello M. Endothelial dysfunction: a key to the pathophysiology and natural history of peripheral arterial disease? Atherosclerosis. 2008; 197: 1\u201311.","DOI":"10.1016\/j.atherosclerosis.2007.11.002"},{"key":"ref74","doi-asserted-by":"crossref","unstructured":"Taleb S. Inflammation in atherosclerosis. Archives of Cardiovascular Diseases. 2016; 109: 708\u2013715.","DOI":"10.1016\/j.acvd.2016.04.002"},{"key":"ref75","unstructured":"Garfield E. Journal impact factor: a brief review. Canadian Medical Association Journal. 1999; 161: 979\u2013980."},{"key":"ref76","doi-asserted-by":"crossref","unstructured":"Groneberg-Kloft B, Fischer TC, Quarcoo D, Scutaru C. New quality and quantity indices in science (NewQIS): the study protocol of an international project. Journal of Occupational Medicine and Toxicology. 2009; 4: 16.","DOI":"10.1186\/1745-6673-4-16"},{"key":"ref77","doi-asserted-by":"crossref","unstructured":"Chen C. CiteSpace II: Detecting and visualizing emerging trends and transient patterns in scientific literature. Journal of the American Society for Information Science and Technology. 2006; 57: 359\u2013377.","DOI":"10.1002\/asi.20317"},{"key":"ref78","doi-asserted-by":"crossref","unstructured":"Chen C. Searching for intellectual turning points: Progressive knowledge domain visualization. Proceedings of the National Academy of Sciences. 2004; 101: 5303\u20135310.","DOI":"10.1073\/pnas.0307513100"},{"key":"ref79","doi-asserted-by":"crossref","unstructured":"Chen C, Ibekwe-Sanjuan F, Hou J. The structure and dynamics of co-citation clusters: a multiple-perspective co-citation analysis. Journal of the Association for Information Science and Technology. 2010; 61: 1386\u20131409.","DOI":"10.1002\/asi.21309"},{"key":"ref80","doi-asserted-by":"crossref","unstructured":"van Eck NJ, Waltman L. Software survey: VOSviewer, a computer program for bibliometric mapping. Scientometrics. 2010; 84: 523\u2013538.","DOI":"10.1007\/s11192-009-0146-3"},{"key":"ref81","doi-asserted-by":"crossref","unstructured":"de Laat M, Lally V, Lipponen L, Simons R. Investigating patterns of interaction in networked learning and computer-supported collaborative learning: a role for Social Network Analysis. International Journal of Computer-Supported Collaborative Learning. 2007; 2: 87\u2013103.","DOI":"10.1007\/s11412-007-9006-4"},{"key":"ref82","doi-asserted-by":"crossref","unstructured":"Kessler MM. Bibliographic coupling between scientific papers. American Documentation. 1963; 14: 10\u201325.","DOI":"10.1002\/asi.5090140103"},{"key":"ref83","unstructured":"Marshakova I. System of document connections based on references. Scientific and Technical Information (VINITI). 1973; 6: 3\u20138."},{"key":"ref84","doi-asserted-by":"crossref","unstructured":"Small H. Co-citation in the scientific literature: a new measure of the relationship between two documents. Journal of the American Society for Information Science. 1973; 24: 265\u2013269.","DOI":"10.1002\/asi.4630240406"},{"key":"ref85","doi-asserted-by":"crossref","unstructured":"Patsopoulos NA, Ioannidis JPA, Analatos AA. Origin and funding of the most frequently cited papers in medicine: database analysis. British Medical Journal. 2006; 332: 1061\u20131064.","DOI":"10.1136\/bmj.38768.420139.80"},{"key":"ref86","doi-asserted-by":"crossref","unstructured":"Garfield E. How can impact factors be improved? British Medical Journal. 1996; 313: 411\u2013413.","DOI":"10.1136\/bmj.313.7054.411"},{"key":"ref87","doi-asserted-by":"crossref","unstructured":"Robbins CS, Hilgendorf I, Weber GF, Theurl I, Iwamoto Y, Figueiredo J, et al. Local proliferation dominates lesional macrophage accumulation in atherosclerosis. Nature Medicine. 2013; 19: 1166\u20131172.","DOI":"10.1038\/nm.3258"},{"key":"ref88","doi-asserted-by":"crossref","unstructured":"Dutta P, Courties G, Wei Y, Leuschner F, Gorbatov R, Robbins CS, et al. Myocardial infarction accelerates atherosclerosis. Nature. 2012; 487: 325\u2013329.","DOI":"10.1038\/nature11260"},{"key":"ref89","doi-asserted-by":"crossref","unstructured":"Antonopoulos AS, Sanna F, Sabharwal N, Thomas S, Oikonomou EK, Herdman L, et al. Detecting human coronary inflammation by imaging perivascular fat. Science Translational Medicine. 2017; 9: eaal2658.","DOI":"10.1126\/scitranslmed.aal2658"},{"key":"ref90","doi-asserted-by":"crossref","unstructured":"Libby P, Ridker PM, Hansson GK. Progress and challenges in translating the biology of atherosclerosis. Nature. 2011; 473: 317\u2013325.","DOI":"10.1038\/nature10146"},{"key":"ref91","doi-asserted-by":"crossref","unstructured":"Hansson GK, Hermansson A. The immune system in atherosclerosis. Nature Immunology. 2011; 12: 204\u2013212.","DOI":"10.1038\/ni.2001"},{"key":"ref92","doi-asserted-by":"crossref","unstructured":"Zupic I, \u010cater T. Bibliometric Methods in Management and Organization. Organizational Research Methods. 2015; 18: 429\u2013472.","DOI":"10.1177\/1094428114562629"},{"key":"ref93","doi-asserted-by":"crossref","unstructured":"Callon M, Courtial JP, Laville F. Co-word analysis as a tool for describing the network of interactions between basic and technological research: the case of polymer chemsitry. Scientometrics. 1991; 22: 155\u2013205.","DOI":"10.1007\/BF02019280"},{"key":"ref94","doi-asserted-by":"crossref","unstructured":"Cambrosio A, Limoges C, Courtial JP, Laville F. Historical scientometrics? Mapping over 70 years of biological safety research with coword analysis. Scientometrics. 1993; 27: 119\u2013143.","DOI":"10.1007\/BF02016546"},{"key":"ref95","doi-asserted-by":"crossref","unstructured":"Fitzpatrick RB. Essential Science Indicators. Medical Reference Services Quarterly. 2005; 24: 67\u201378.","DOI":"10.1300\/J115v24n04_05"},{"key":"ref96","doi-asserted-by":"crossref","unstructured":"Stout NL, Alfano CM, Belter CW, Nitkin R, Cernich A, Lohmann Siegel K, et al. A Bibliometric Analysis of the Landscape of Cancer Rehabilitation Research (1992\u20132016). Journal of the National Cancer Institute. 2018; 110: 815\u2013824.","DOI":"10.1093\/jnci\/djy108"},{"key":"ref97","doi-asserted-by":"crossref","unstructured":"Peeters A, Mullins G, Becker D, Orellana L, Livingston P. COVID-19\u2019s impact on Australia\u2019s health research workforce. The Lancet. 2020; 396: 461.","DOI":"10.1016\/S0140-6736(20)31533-6"},{"key":"ref98","doi-asserted-by":"crossref","unstructured":"Webster P. How is biomedical research funding faring during the COVID-19 lockdown? Nature Medicine. 2020.","DOI":"10.1038\/d41591-020-00010-4"},{"key":"ref99","unstructured":"Betweenness centrality. 2016. Available at:https:\/\/enwikipediaorg\/wiki\/Betweenness_centrality (Accessed: 10 August 2016)."},{"key":"ref100","doi-asserted-by":"crossref","unstructured":"Cobo MJ, L\u00f3pez-Herrera AG, Herrera-Viedma E, Herrera F. An approach for detecting, quantifying, and visualizing the evolution of a research field: a practical application to the Fuzzy Sets Theory field. Journal of Informetrics. 2011; 5: 146\u2013166.","DOI":"10.1016\/j.joi.2010.10.002"},{"key":"ref101","doi-asserted-by":"crossref","unstructured":"Katz JS, Martin BR. What is research collaboration? Research Policy. 1997; 26: 1\u201318.","DOI":"10.1016\/S0048-7333(96)00917-1"},{"key":"ref102","doi-asserted-by":"crossref","unstructured":"Wuchty S, Jones BF, Uzzi B. The Increasing Dominance of Teams in Production of Knowledge. Science. 2007; 316: 1036\u20131039.","DOI":"10.1126\/science.1136099"},{"key":"ref103","doi-asserted-by":"crossref","unstructured":"Hou J, Yang X, Chen C. Emerging trends and new developments in information science: a document co-citation analysis (2009\u20132016). Scientometrics. 2018; 115: 869\u2013892.","DOI":"10.1007\/s11192-018-2695-9"},{"key":"ref104","doi-asserted-by":"crossref","unstructured":"Libby P, Buring JE, Badimon L, Hansson GK, Deanfield J, Bittencourt MS, et al. Atherosclerosis. Nature Reviews Disease Primers. 2019; 5: 56.","DOI":"10.1038\/s41572-019-0106-z"},{"key":"ref105","doi-asserted-by":"crossref","unstructured":"Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, et al. Wytyczne ESC dotycz\u0105ce post\u0119powania w ostrym zawale serca z uniesieniem odcinka ST w 2017 roku. Kardiologia Polska. 2018; 76: 229\u2013313.","DOI":"10.5603\/KP.2018.0041"},{"key":"ref106","doi-asserted-by":"crossref","unstructured":"B\u00e4ck M, Yurdagul A Jr, Tabas I, \u00d6\u00f6rni K, Kovanen PT. Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities. Nature Reviews Cardiology. 2019; 16: 389\u2013406.","DOI":"10.1038\/s41569-019-0169-2"},{"key":"ref107","doi-asserted-by":"crossref","unstructured":"Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, et al. Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association. Circulation. 2019; 139: e56\u2013e528. Erratum in: Circulation. 2020; 141: e33.","DOI":"10.1161\/CIR.0000000000000746"},{"key":"ref108","doi-asserted-by":"crossref","unstructured":"Rajam\u00e4ki K, Lappalainen J, O\u00f6rni K, V\u00e4lim\u00e4ki E, Matikainen S, Kovanen PT, et al. Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation. PLoS ONE. 2010; 5: e11765.","DOI":"10.1371\/journal.pone.0011765"},{"key":"ref109","doi-asserted-by":"crossref","unstructured":"Hoseini Z, Sepahvand F, Rashidi B, Sahebkar A, Masoudifar A, Mirzaei H. NLRP3 inflammasome: Its regulation and involvement in atherosclerosis. Journal of cellular physiology. 2018; 233: 2116-2132.","DOI":"10.1002\/jcp.25930"},{"key":"ref110","doi-asserted-by":"crossref","unstructured":"Duewell P, Kono H, Rayner KJ, Sirois CM, Vladimer G, Bauernfeind FG, et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature. 2010; 464: 1357\u20131361. Erratum in: Nature. 2010; 466: 652.","DOI":"10.1038\/nature08938"},{"key":"ref111","doi-asserted-by":"crossref","unstructured":"van der Heijden T, Kritikou E, Venema W, van Duijn J, van Santbrink PJ, Sl\u00fctter B, et al. NLRP3 Inflammasome Inhibition by MCC950 Reduces Atherosclerotic Lesion Development in Apolipoprotein E\u2013Deficient Mice\u2014Brief Report. Arteriosclerosis, Thrombosis, and Vascular Biology. 2017; 37: 1457\u20131461.","DOI":"10.1161\/ATVBAHA.117.309575"},{"key":"ref112","doi-asserted-by":"crossref","unstructured":"Ridker PM. From C-Reactive Protein to Interleukin-6 to Interleukin-1: Moving Upstream To Identify Novel Targets for Atheroprotection. Circulation Research. 2016; 118: 145\u2013156.","DOI":"10.1161\/CIRCRESAHA.115.306656"},{"key":"ref113","doi-asserted-by":"crossref","unstructured":"Sun Q, Fan J, Billiar TR, Scott MJ. Inflammasome and Autophagy Regulation: a Two-way Street. Molecular Medicine. 2017; 23: 188\u2013195.","DOI":"10.2119\/molmed.2017.00077"},{"key":"ref114","doi-asserted-by":"crossref","unstructured":"Onat UI, Yildirim AD, Tufanli \u00d6, \u00c7imen I, Kocat\u00fcrk B, Veli Z, et al. Intercepting the Lipid-Induced Integrated Stress Response Reduces Atherosclerosis. Journal of the American College of Cardiology. 2019; 73: 1149\u20131169.","DOI":"10.1016\/j.jacc.2018.12.055"},{"key":"ref115","doi-asserted-by":"crossref","unstructured":"Razani B, Feng C, Coleman T, Emanuel R, Wen H, Hwang S, et al. Autophagy Links Inflammasomes to Atherosclerotic Progression. Cell Metabolism. 2012; 15: 534\u2013544.","DOI":"10.1016\/j.cmet.2012.02.011"},{"key":"ref116","doi-asserted-by":"crossref","unstructured":"Pols TH, Nomura M, Harach T, Lo Sasso G, Oosterveer M, Thomas C, et al. TGR5 Activation Inhibits Atherosclerosis by Reducing Macrophage Inflammation and Lipid Loading. Cell Metabolism. 2011; 14: 747\u2013757.","DOI":"10.1016\/j.cmet.2011.11.006"},{"key":"ref117","doi-asserted-by":"crossref","unstructured":"Ridker PM. Anti-inflammatory therapy for atherosclerosis: interpreting divergent results from the CANTOS and CIRT clinical trials. Journal of Internal Medicine. 2019; 285: 503\u2013509.","DOI":"10.1111\/joim.12862"},{"key":"ref118","doi-asserted-by":"crossref","unstructured":"IL6R Genetics Consortium Emerging Risk Factors Collaboration, Sarwar N, Butterworth AS, Freitag DF, Gregson J, Willeit P, et al. Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies. Lancet. 2012; 379: 1205\u20131213.","DOI":"10.1016\/S0140-6736(11)61931-4"},{"key":"ref119","doi-asserted-by":"crossref","unstructured":"Roediger WEW. Utilization of Nutrients by Isolated Epithelial Cells of the Rat Colon. Gastroenterology. 1982; 83: 424\u2013429.","DOI":"10.1016\/S0016-5085(82)80339-9"},{"key":"ref120","doi-asserted-by":"crossref","unstructured":"Edfeldt K, Swedenborg J, Hansson GK, Yan Z. Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation. Circulation. 2002; 105: 1158\u20131161.","DOI":"10.1161\/circ.105.10.1158"},{"key":"ref121","doi-asserted-by":"crossref","unstructured":"Karlsson FH, F\u00e5k F, Nookaew I, Tremaroli V, Fagerberg B, Petranovic D, et al. Symptomatic atherosclerosis is associated with an altered gut metagenome. Nature Communications. 2012; 3: 1245.","DOI":"10.1038\/ncomms2266"},{"key":"ref122","doi-asserted-by":"crossref","unstructured":"Furusawa Y, Obata Y, Fukuda S, Endo TA, Nakato G, Takahashi D, et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature. 2013; 504: 446\u2013450.","DOI":"10.1038\/nature12721"},{"key":"ref123","doi-asserted-by":"crossref","unstructured":"Wang Z, Roberts A, Buffa J, Levison B, Zhu W, Org E, et al. Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis. Cell. 2015; 163: 1585\u20131595.","DOI":"10.1016\/j.cell.2015.11.055"},{"key":"ref124","doi-asserted-by":"crossref","unstructured":"Wang Z, Klipfell E, Bennett BJ, Koeth R, Levison BS, DuGar B, et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature. 2011; 472: 57\u201363.","DOI":"10.1038\/nature09922"},{"key":"ref125","doi-asserted-by":"crossref","unstructured":"Geng J, Yang C, Wang B, Zhang X, Hu T, Gu Y, et al. Trimethylamine N-oxide promotes atherosclerosis via CD36-dependent MAPK\/JNK pathway. Biomedicine & Pharmacotherapy. 2018; 97: 941\u2013947.","DOI":"10.1016\/j.biopha.2017.11.016"},{"key":"ref126","doi-asserted-by":"crossref","unstructured":"Seldin MM, Meng Y, Qi H, Zhu W, Wang Z, Hazen SL, et al. Trimethylamine N-Oxide Promotes Vascular Inflammation through Signaling of Mitogen-Activated Protein Kinase and Nuclear Factor\u2010\u03baB. Journal of the American Heart Association. 2016; 5: e002767.","DOI":"10.1161\/JAHA.115.002767"},{"key":"ref127","doi-asserted-by":"crossref","unstructured":"Zhu W, Gregory JC, Org E, Buffa JA, Gupta N, Wang Z, et al. Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk. Cell. 2016; 165: 111\u2013124.","DOI":"10.1016\/j.cell.2016.02.011"},{"key":"ref128","doi-asserted-by":"crossref","unstructured":"Senthong V, Li XS, Hudec T, Coughlin J, Wu Y, Levison B, et al. Plasma Trimethylamine N-Oxide, a Gut Microbe\u2013Generated Phosphatidylcholine Metabolite, is Associated with Atherosclerotic Burden. Journal of the American College of Cardiology. 2016; 67: 2620\u20132628.","DOI":"10.1016\/j.jacc.2016.03.546"},{"key":"ref129","doi-asserted-by":"crossref","unstructured":"Senthong V, Wang Z, Li XS, Fan Y, Wu Y, Tang WH, et al. Intestinal Microbiota-Generated Metabolite Trimethylamine-N-Oxide and 5-Year Mortality Risk in Stable Coronary Artery Disease: The Contributory Role of Intestinal Microbiota in a COURAGE-Like Patient Cohort. Journal of the American Heart Association. 2016; 5: e002816.","DOI":"10.1161\/JAHA.115.002816"},{"key":"ref130","doi-asserted-by":"crossref","unstructured":"Chen ML, Yi L, Zhang Y, Zhou X, Ran L, Yang J, et al. Resveratrol Attenuates Trimethylamine-N-Oxide (TMAO)-Induced Atherosclerosis by Regulating TMAO Synthesis and Bile Acid Metabolism via Remodeling of the Gut Microbiota. mBio. 2016; 7: e02210-15.","DOI":"10.1128\/mBio.02210-15"},{"key":"ref131","doi-asserted-by":"crossref","unstructured":"Lindskog Jonsson A, Caesar R, Akrami R, Reinhardt C, F\u00e5k H\u00e5llenius F, Bor\u00e9n J, et al. Impact of Gut Microbiota and Diet on the Development of Atherosclerosis in Apoe-\/- Mice. Arteriosclerosis, Thrombosis, and Vascular Biology. 2018; 38: 2318\u20132326.","DOI":"10.1161\/ATVBAHA.118.311233"},{"key":"ref132","doi-asserted-by":"crossref","unstructured":"Wu Q, Hu Y, Jiang M, Wang F, Gong G. Effect of Autophagy Regulated by Sirt1\/FoxO1 Pathway on the Release of Factors Promoting Thrombosis from Vascular Endothelial Cells. International Journal of Molecular Sciences. 2019; 20: 4132.","DOI":"10.3390\/ijms20174132"},{"key":"ref133","doi-asserted-by":"crossref","unstructured":"Pankratz F, Hohnloser C, Bemtgen X, Jaenich C, Kreuzaler S, Hoefer I, et al. MicroRNA-100 Suppresses Chronic Vascular Inflammation by Stimulation of Endothelial Autophagy. Circulation Research. 2018; 122: 417\u2013432.","DOI":"10.1161\/CIRCRESAHA.117.311428"},{"key":"ref134","doi-asserted-by":"crossref","unstructured":"Zhou Y, Cao Z, Wang H, Cheng Y, Yu L, Zhang X, et al. The anti-inflammatory effects of Morin hydrate in atherosclerosis is associated with autophagy induction through cAMP signaling. Molecular Nutrition & Food Research. 2017; 61: 1600966.","DOI":"10.1002\/mnfr.201600966"},{"key":"ref135","doi-asserted-by":"crossref","unstructured":"Martinet W, De Meyer GRY. Autophagy in atherosclerosis: a cell survival and death phenomenon with therapeutic potential. Circulation Research. 2009; 104: 304\u2013317.","DOI":"10.1161\/CIRCRESAHA.108.188318"},{"key":"ref136","doi-asserted-by":"crossref","unstructured":"Chen P, Wang K, Chao T, Chung H, Tseng S, Luo C, et al. Recombinant Thrombomodulin Exerts Anti-autophagic Action in Endothelial Cells and Provides Anti-atherosclerosis Effect in Apolipoprotein E Deficient Mice. Scientific Reports. 2017; 7: 3284.","DOI":"10.1038\/s41598-017-03443-z"},{"key":"ref137","doi-asserted-by":"crossref","unstructured":"Pi S, Mao L, Chen J, Shi H, Liu Y, Guo X, et al. The P2RY12 receptor promotes VSMC-derived foam cell formation by inhibiting autophagy in advanced atherosclerosis. Autophagy. 2021; 17: 980\u20131000.","DOI":"10.1080\/15548627.2020.1741202"},{"key":"ref138","unstructured":"Wu W, Shan Z, Wang R, Chang G, Wang M, Wu R, et al. Overexpression of miR-223 inhibits foam cell formation by inducing autophagy in vascular smooth muscle cells. American Journal of Translational Research. 2019; 11: 4326\u20134336."},{"key":"ref139","doi-asserted-by":"crossref","unstructured":"Wu H, Song A, Hu W, Dai M. The Anti-atherosclerotic Effect of Paeonol against Vascular Smooth Muscle Cell Proliferation by Up-regulation of Autophagy via the AMPK\/mTOR Signaling Pathway. Frontiers in Pharmacology. 2018; 8: 948.","DOI":"10.3389\/fphar.2017.00948"},{"key":"ref140","doi-asserted-by":"crossref","unstructured":"Li D, Chen A, Lan T, Zou Y, Zhao L, Yang P, et al. SCAP knockdown in vascular smooth muscle cells alleviates atherosclerosis plaque formation via up-regulating autophagy in ApoE-\/- mice. The FASEB Journal. 2019; 33: 3437\u20133450.","DOI":"10.1096\/fj.201800975RRR"},{"key":"ref141","doi-asserted-by":"crossref","unstructured":"Grootaert MO, da Costa Martins PA, Bitsch N, Pintelon I, De Meyer GR, Martinet W, et al. Defective autophagy in vascular smooth muscle cells accelerates senescence and promotes neointima formation and atherogenesis. Autophagy. 2015; 11: 2014\u20132032.","DOI":"10.1080\/15548627.2015.1096485"},{"key":"ref142","doi-asserted-by":"crossref","unstructured":"Gardner SE, Humphry M, Bennett MR, Clarke MCH. Senescent Vascular Smooth Muscle Cells Drive Inflammation through an Interleukin-1\u03b1\u2013Dependent Senescence-Associated Secretory Phenotype. Arteriosclerosis, Thrombosis, and Vascular Biology. 2015; 35: 1963\u20131974.","DOI":"10.1161\/ATVBAHA.115.305896"},{"key":"ref143","doi-asserted-by":"crossref","unstructured":"Mei Y, Thompson MD, Cohen RA, Tong X. Autophagy and oxidative stress in cardiovascular diseases. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2015; 1852: 243\u2013251.","DOI":"10.1016\/j.bbadis.2014.05.005"},{"key":"ref144","doi-asserted-by":"crossref","unstructured":"Zhai C, Cheng J, Mujahid H, Wang H, Kong J, Yin Y, et al. Selective inhibition of PI3K\/Akt\/mTOR signaling pathway regulates autophagy of macrophage and vulnerability of atherosclerotic plaque. PLoS ONE. 2014; 9: e90563.","DOI":"10.1371\/journal.pone.0090563"},{"key":"ref145","doi-asserted-by":"crossref","unstructured":"Zhou Z, Zhu X, Yin R, Liu T, Yang S, Zhou L, et al. K63 ubiquitin chains target NLRP3 inflammasome for autophagic degradation in ox-LDL-stimulated THP-1 macrophages. Aging. 2020; 12: 1747\u20131759.","DOI":"10.18632\/aging.102710"},{"key":"ref146","doi-asserted-by":"crossref","unstructured":"Liao X, Sluimer J, Wang Y, Subramanian M, Brown K, Pattison JS, et al. Macrophage Autophagy Plays a Protective Role in Advanced Atherosclerosis. Cell Metabolism. 2012; 15: 545\u2013553.","DOI":"10.1016\/j.cmet.2012.01.022"},{"key":"ref147","doi-asserted-by":"crossref","unstructured":"Guo F, Wu Q, Li P, Zheng L, Ye S, Dai X, et al. The role of the LncRNA-FA2H-2-MLKL pathway in atherosclerosis by regulation of autophagy flux and inflammation through mTOR-dependent signaling. Cell Death & Differentiation. 2019; 26: 1670\u20131687.","DOI":"10.1038\/s41418-018-0235-z"},{"key":"ref148","doi-asserted-by":"crossref","unstructured":"Cremer S, Michalik KM, Fischer A, Pfisterer L, Ja\u00e9 N, Winter C, et al. Hematopoietic Deficiency of the Long Noncoding RNA MALAT1 Promotes Atherosclerosis and Plaque Inflammation. Circulation. 2019; 139: 1320\u20131334. Erratum in: Circulation. 2019; 140: e161.","DOI":"10.1161\/CIRCULATIONAHA.117.029015"},{"key":"ref149","doi-asserted-by":"crossref","unstructured":"F\u00e9vrier B, Raposo G. Exosomes: endosomal-derived vesicles shipping extracellular messages. Current Opinion in Cell Biology. 2004; 16: 415\u2013421.","DOI":"10.1016\/j.ceb.2004.06.003"},{"key":"ref150","doi-asserted-by":"crossref","unstructured":"Hu N, Zeng X, Tang F, Xiong S. Exosomal long non-coding RNA LIPCAR derived from oxLDL-treated THP-1 cells regulates the proliferation of human umbilical vein endothelial cells and human vascular smooth muscle cells. Biochemical and Biophysical Research Communications. 2021; 575: 65\u201372.","DOI":"10.1016\/j.bbrc.2021.08.053"},{"key":"ref151","unstructured":"Liu Y, Zhang WL, Gu JJ, Sun YQ, Cui HZ, Bu JQ, et al. Exosome-mediated miR-106a-3p derived from ox-LDL exposed macrophages accelerated cell proliferation and repressed cell apoptosis of human vascular smooth muscle cells. European Review for Medical and Pharmacological Sciences. 2020; 24: 7039\u20137050."},{"key":"ref152","doi-asserted-by":"crossref","unstructured":"Chen L, Yang W, Guo Y, Chen W, Zheng P, Zeng J, et al. Exosomal lncRNA GAS5 regulates the apoptosis of macrophages and vascular endothelial cells in atherosclerosis. PLoS ONE. 2017; 12: e0185406.","DOI":"10.1371\/journal.pone.0185406"},{"key":"ref153","doi-asserted-by":"crossref","unstructured":"Gao H, Yu Z, Li Y, Wang X. MiR-100-5p in human umbilical cord mesenchymal stem cell-derived exosomes mediates eosinophilic inflammation to alleviate atherosclerosis via the FZD5\/Wnt\/\u03b2-catenin pathway. Acta Biochimica et Biophysica Sinica. 2021; 53: 1166\u20131176.","DOI":"10.1093\/abbs\/gmab093"},{"key":"ref154","doi-asserted-by":"crossref","unstructured":"Bouchareychas L, Duong P, Covarrubias S, Alsop E, Phu TA, Chung A, et al. Macrophage Exosomes Resolve Atherosclerosis by Regulating Hematopoiesis and Inflammation via MicroRNA Cargo. Cell Reports. 2020; 32: 107881.","DOI":"10.1016\/j.celrep.2020.107881"},{"key":"ref155","doi-asserted-by":"crossref","unstructured":"Yao Y, Sun W, Sun Q, Jing B, Liu S, Liu X, et al. Platelet-Derived Exosomal MicroRNA-25-3p Inhibits Coronary Vascular Endothelial Cell Inflammation Through Adam10 via the NF-\u03baB Signaling Pathway in ApoE-\/- Mice. Frontiers in Immunology. 2019; 10: 2205.","DOI":"10.3389\/fimmu.2019.02205"},{"key":"ref156","doi-asserted-by":"crossref","unstructured":"Yuan Z, Huang W. New Developments in Exosomal lncRNAs in Cardiovascular Diseases. Frontiers in Cardiovascular Medicine. 2021; 8: 709169.","DOI":"10.3389\/fcvm.2021.709169"},{"key":"ref157","doi-asserted-by":"crossref","unstructured":"Harada N, Ito K, Hosoya T, Mimura J, Maruyama A, Noguchi N, et al. Nrf2 in bone marrow-derived cells positively contributes to the advanced stage of atherosclerotic plaque formation. Free Radical Biology and Medicine. 2012; 53: 2256\u20132262.","DOI":"10.1016\/j.freeradbiomed.2012.10.001"},{"key":"ref158","doi-asserted-by":"crossref","unstructured":"Freigang S, Ampenberger F, Spohn G, Heer S, Shamshiev AT, Kisielow J, et al. Nrf2 is essential for cholesterol crystal-induced inflammasome activation and exacerbation of atherosclerosis. European Journal of Immunology. 2011; 41: 2040\u20132051.","DOI":"10.1002\/eji.201041316"},{"key":"ref159","doi-asserted-by":"crossref","unstructured":"Barajas B, Che N, Yin F, Rowshanrad A, Orozco LD, Gong KW, et al. NF-E2\u2013Related Factor 2 Promotes Atherosclerosis by Effects on Plasma Lipoproteins and Cholesterol Transport that Overshadow Antioxidant Protection. Arteriosclerosis, Thrombosis, and Vascular Biology. 2011; 31: 58\u201366.","DOI":"10.1161\/ATVBAHA.110.210906"},{"key":"ref160","doi-asserted-by":"crossref","unstructured":"Sussan TE, Jun J, Thimmulappa R, Bedja D, Antero M, Gabrielson KL, et al. Disruption of Nrf2, a key inducer of antioxidant defenses, attenuates ApoE-mediated atherosclerosis in mice. PLoS ONE. 2008; 3: e3791.","DOI":"10.1371\/journal.pone.0003791"},{"key":"ref161","doi-asserted-by":"crossref","unstructured":"Ishii T, Itoh K, Ruiz E, Leake DS, Unoki H, Yamamoto M, et al. Role of Nrf2 in the regulation of CD36 and stress protein expression in murine macrophages: activation by oxidatively modified LDL and 4-hydroxynonenal. Circulation Research. 2004; 94: 609\u2013616.","DOI":"10.1161\/01.RES.0000119171.44657.45"},{"key":"ref162","doi-asserted-by":"crossref","unstructured":"Ren J, Su D, Li L, Cai H, Zhang M, Zhai J, et al. Anti-inflammatory effects of Aureusidin in LPS-stimulated RAW264.7 macrophages via suppressing NF-\u03baB and activating ROS- and MAPKs-dependent Nrf2\/HO-1 signaling pathways. Toxicology and Applied Pharmacology. 2020; 387: 114846.","DOI":"10.1016\/j.taap.2019.114846"},{"key":"ref163","doi-asserted-by":"crossref","unstructured":"Hu Q, Zhang T, Yi L, Zhou X, Mi M. Dihydromyricetin inhibits NLRP3 inflammasome-dependent pyroptosis by activating the Nrf2 signaling pathway in vascular endothelial cells. BioFactors. 2018; 44: 123\u2013136.","DOI":"10.1002\/biof.1395"},{"key":"ref164","doi-asserted-by":"crossref","unstructured":"Zhang Q, Liu J, Duan H, Li R, Peng W, Wu C. Activation of Nrf2\/HO-1 signaling: an important molecular mechanism of herbal medicine in the treatment of atherosclerosis via the protection of vascular endothelial cells from oxidative stress. Journal of Advanced Research. 2021; 34: 43\u201363.","DOI":"10.1016\/j.jare.2021.06.023"},{"key":"ref165","doi-asserted-by":"crossref","unstructured":"Kirii H, Niwa T, Yamada Y, Wada H, Saito K, Iwakura Y, et al. Lack of interleukin-1beta decreases the severity of atherosclerosis in ApoE-deficient mice. Arteriosclerosis, Thrombosis, and Vascular Biology. 2003; 23: 656\u2013660.","DOI":"10.1161\/01.ATV.0000064374.15232.C3"},{"key":"ref166","doi-asserted-by":"crossref","unstructured":"Mallat Z, Corbaz A, Scoazec A, Graber P, Alouani S, Esposito B, et al. Interleukin-18\/Interleukin-18 Binding Protein Signaling Modulates Atherosclerotic Lesion Development and Stability. Circulation Research. 2001; 89: E41\u2013E45.","DOI":"10.1161\/hh1901.098735"},{"key":"ref167","doi-asserted-by":"crossref","unstructured":"Ridker PM, Rifai N, Pfeffer MA, Sacks F, Braunwald E. Long-Term Effects of Pravastatin on Plasma Concentration of C-reactive Protein. The Cholesterol and Recurrent Events (CARE) Investigators. Circulation. 1999; 100: 230\u2013235.","DOI":"10.1161\/01.CIR.100.3.230"},{"key":"ref168","doi-asserted-by":"crossref","unstructured":"Albert MA, Danielson E, Rifai N, Ridker PM, for the PRINCE Investigators. Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation\/CRP evaluation (PRINCE): a randomized trial and cohort study. Journal of the American Medical Association. 2001; 286: 64.","DOI":"10.1001\/jama.286.1.64"},{"key":"ref169","doi-asserted-by":"crossref","unstructured":"Ridker PM, Rifai N, Clearfield M, Downs JR, Weis SE, Miles JS, et al. Measurement of C-Reactive Protein for the Targeting of Statin Therapy in the Primary Prevention of Acute Coronary Events. New England Journal of Medicine. 2001; 344: 1959\u20131965.","DOI":"10.1056\/NEJM200106283442601"},{"key":"ref170","doi-asserted-by":"crossref","unstructured":"Ridker PM, Cannon CP, Morrow D, Rifai N, Rose LM, McCabe CH, et al. C-Reactive Protein Levels and Outcomes after Statin Therapy. New England Journal of Medicine. 2005; 352: 20\u201328.","DOI":"10.1056\/NEJMoa042378"},{"key":"ref171","doi-asserted-by":"crossref","unstructured":"Bohula EA, Giugliano RP, Cannon CP, Zhou J, Murphy SA, White JA, et al. Achievement of Dual Low-Density Lipoprotein Cholesterol and High-Sensitivity C-Reactive Protein Targets more Frequent with the Addition of Ezetimibe to Simvastatin and Associated with Better Outcomes in IMPROVE-it. Circulation. 2015; 132: 1224\u20131233.","DOI":"10.1161\/CIRCULATIONAHA.115.018381"},{"key":"ref172","doi-asserted-by":"crossref","unstructured":"Ridker PM, Danielson E, Fonseca FAH, Genest J, Gotto AM, Kastelein JJP, et al. Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein. New England Journal of Medicine. 2008; 359: 2195\u20132207.","DOI":"10.1056\/NEJMoa0807646"},{"key":"ref173","doi-asserted-by":"crossref","unstructured":"Dhindsa DS, Sandesara PB, Shapiro MD, Wong ND. The Evolving Understanding and Approach to Residual Cardiovascular Risk Management. Frontiers in Cardiovascular Medicine. 2020; 7: 88.","DOI":"10.3389\/fcvm.2020.00088"},{"key":"ref174","doi-asserted-by":"crossref","unstructured":"Rubin J, Chang H, Nasir K, Blumenthal RS, Blaha MJ, Choi E, et al. Association between High-Sensitivity C-Reactive Protein and Coronary Plaque Subtypes Assessed by 64-Slice Coronary Computed Tomography Angiography in an Asymptomatic Population. Circulation: Cardiovascular Imaging. 2011; 4: 201\u2013209.","DOI":"10.1161\/CIRCIMAGING.109.929901"},{"key":"ref175","doi-asserted-by":"crossref","unstructured":"Ridker PM, Hennekens CH, Buring JE, Rifai N. C-Reactive Protein and other Markers of Inflammation in the Prediction of Cardiovascular Disease in Women. New England Journal of Medicine. 2000; 342: 836\u2013843.","DOI":"10.1056\/NEJM200003233421202"},{"key":"ref176","doi-asserted-by":"crossref","unstructured":"Elliott P. Genetic Loci Associated with C-Reactive Protein Levels and Risk of Coronary Heart Disease. Journal of the American Medical Association. 2009; 302: 37.","DOI":"10.1001\/jama.2009.954"},{"key":"ref177","doi-asserted-by":"crossref","unstructured":"Ridker PM. A Test in Context: High-Sensitivity C-Reactive Protein. Journal of the American College of Cardiology. 2016; 67: 712\u2013723.","DOI":"10.1016\/j.jacc.2015.11.037"},{"key":"ref178","doi-asserted-by":"crossref","unstructured":"Libby P. Inflammation in Atherosclerosis\u2014no Longer a Theory. Clinical Chemistry. 2021; 67: 131\u2013142.","DOI":"10.1093\/clinchem\/hvaa275"},{"key":"ref179","doi-asserted-by":"crossref","unstructured":"Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM, Kastelein JJ, et al. Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial. The Lancet. 2009; 373: 1175\u20131182.","DOI":"10.1016\/S0140-6736(09)60447-5"},{"key":"ref180","doi-asserted-by":"crossref","unstructured":"Grebe A, Hoss F, Latz E. NLRP3 Inflammasome and the IL-1 Pathway in Atherosclerosis. Circulation Research. 2018; 122: 1722\u20131740.","DOI":"10.1161\/CIRCRESAHA.118.311362"},{"key":"ref181","doi-asserted-by":"crossref","unstructured":"Kumar A, Thota V, Dee L, Olson J, Uretz E, Parrillo JE. Tumor necrosis factor alpha and interleukin 1beta are responsible for in vitro myocardial cell depression induced by human septic shock serum. Journal of Experimental Medicine. 1996; 183: 949\u2013958.","DOI":"10.1084\/jem.183.3.949"},{"key":"ref182","doi-asserted-by":"crossref","unstructured":"Ridker PM, Everett BM, Pradhan A, MacFadyen JG, Solomon DH, Zaharris E, et al. Low-Dose Methotrexate for the Prevention of Atherosclerotic Events. New England Journal of Medicine. 2019; 380: 752\u2013762.","DOI":"10.1056\/NEJMoa1809798"},{"key":"ref183","doi-asserted-by":"crossref","unstructured":"Ott SJ, El Mokhtari NE, Musfeldt M, Hellmig S, Freitag S, Rehman A, et al. Detection of Diverse Bacterial Signatures in Atherosclerotic Lesions of Patients with Coronary Heart Disease. Circulation. 2006; 113: 929\u2013937.","DOI":"10.1161\/CIRCULATIONAHA.105.579979"},{"key":"ref184","doi-asserted-by":"crossref","unstructured":"Koren O, Spor A, Felin J, F\u00e5k F, Stombaugh J, Tremaroli V, et al. Human oral, gut, and plaque microbiota in patients with atherosclerosis. Proceedings of the National Academy of Sciences. 2011; 108: 4592\u20134598.","DOI":"10.1073\/pnas.1011383107"},{"key":"ref185","doi-asserted-by":"crossref","unstructured":"Lanter BB, Sauer K, Davies DG. Bacteria Present in Carotid Arterial Plaques are Found as Biofilm Deposits which may Contribute to Enhanced Risk of Plaque Rupture. mBio. 2014; 5: e01206-14.","DOI":"10.1128\/mBio.01206-14"},{"key":"ref186","doi-asserted-by":"crossref","unstructured":"Mitra S, Drautz-Moses DI, Alhede M, Maw MT, Liu Y, Purbojati RW, et al. In silico analyses of metagenomes from human atherosclerotic plaque samples. Microbiome. 2015; 3: 38.","DOI":"10.1186\/s40168-015-0100-y"},{"key":"ref187","doi-asserted-by":"crossref","unstructured":"Epstein SE, Zhu J, Burnett MS, Zhou YF, Vercellotti G, Hajjar D. Infection and atherosclerosis: potential roles of pathogen burden and molecular mimicry. Arteriosclerosis, Thrombosis, and Vascular Biology. 2000; 20: 1417\u20131420.","DOI":"10.1161\/01.ATV.20.6.1417"},{"key":"ref188","doi-asserted-by":"crossref","unstructured":"Grayston JT. Antibiotic Treatment of Atherosclerotic Cardiovascular Disease. Circulation. 2003; 107: 1228\u20131230.","DOI":"10.1161\/01.CIR.0000056032.56396.89"},{"key":"ref189","doi-asserted-by":"crossref","unstructured":"Lagier J, Khelaifia S, Alou MT, Ndongo S, Dione N, Hugon P, et al. Culture of previously uncultured members of the human gut microbiota by culturomics. Nature Microbiology. 2016; 1: 16203.","DOI":"10.1038\/nmicrobiol.2016.203"},{"key":"ref190","doi-asserted-by":"crossref","unstructured":"Jie Z, Xia H, Zhong S, Feng Q, Li S, Liang S, et al. The gut microbiome in atherosclerotic cardiovascular disease. Nature Communications. 2017; 8: 845.","DOI":"10.1038\/s41467-017-00900-1"},{"key":"ref191","doi-asserted-by":"crossref","unstructured":"Liu H, Chen X, Hu X, Niu H, Tian R, Wang H, et al. Alterations in the gut microbiome and metabolism with coronary artery disease severity. Microbiome. 2019; 7: 68.","DOI":"10.1186\/s40168-019-0683-9"},{"key":"ref192","doi-asserted-by":"crossref","unstructured":"Brandsma E, Kloosterhuis NJ, Koster M, Dekker DC, Gijbels MJJ, van der Velden S, et al. A Proinflammatory Gut Microbiota Increases Systemic Inflammation and Accelerates Atherosclerosis. Circulation Research. 2019; 124: 94\u2013100.","DOI":"10.1161\/CIRCRESAHA.118.313234"},{"key":"ref193","doi-asserted-by":"crossref","unstructured":"Perrotta I. The use of electron microscopy for the detection of autophagy in human atherosclerosis. Micron. 2013; 50: 7\u201313.","DOI":"10.1016\/j.micron.2013.03.007"},{"key":"ref194","doi-asserted-by":"crossref","unstructured":"Liu H, Cao Y, Tong T, Shi J, Zhang Y, Yang Y, et al. Autophagy in atherosclerosis: a phenomenon found in human carotid atherosclerotic plaques. Chinese Medical Journal. 2015; 128: 69\u201374.","DOI":"10.4103\/0366-6999.147815"},{"key":"ref195","doi-asserted-by":"crossref","unstructured":"Lin L, Zhang MX, Zhang L, Zhang D, Li C, Li YL. Autophagy, Pyroptosis, and Ferroptosis: New Regulatory Mechanisms for Atherosclerosis. Frontiers in Cell and Developmental Biology. 2022; 9: 809955.","DOI":"10.3389\/fcell.2021.809955"},{"key":"ref196","doi-asserted-by":"crossref","unstructured":"Ma D, Guan B, Song L, Liu Q, Fan Y, Zhao L, et al. A Bibliometric Analysis of Exosomes in Cardiovascular Diseases From 2001 to 2021. Frontiers in Cardiovascular Medicine. 2021; 8: 734514.","DOI":"10.3389\/fcvm.2021.734514"},{"key":"ref197","doi-asserted-by":"crossref","unstructured":"Shao H, Im H, Castro CM, Breakefield X, Weissleder R, Lee H. New Technologies for Analysis of Extracellular Vesicles. Chemical Reviews. 2018; 118: 1917\u20131950.","DOI":"10.1021\/acs.chemrev.7b00534"},{"key":"ref198","doi-asserted-by":"crossref","unstructured":"Coumans FAW, Brisson AR, Buzas EI, Dignat-George F, Drees EEE, El-Andaloussi S, et al. Methodological Guidelines to Study Extracellular Vesicles. Circulation Research. 2017; 120: 1632\u20131648.","DOI":"10.1161\/CIRCRESAHA.117.309417"},{"key":"ref199","doi-asserted-by":"crossref","unstructured":"Liu F, Vermesh O, Mani V, Ge TJ, Madsen SJ, Sabour A, et al. The Exosome Total Isolation Chip. ACS Nano. 2017; 11: 10712\u201310723.","DOI":"10.1021\/acsnano.7b04878"},{"key":"ref200","doi-asserted-by":"crossref","unstructured":"Wu M, Ouyang Y, Wang Z, Zhang R, Huang PH, Chen C, et al. Isolation of exosomes from whole blood by integrating acoustics and microfluidics. Proceedings of the National Academy of Sciences. 2017; 114: 10584-10589. Erratum in: Proceedings of the National Academy of Sciences. 2020; 117: 28525.","DOI":"10.1073\/pnas.1709210114"},{"key":"ref201","doi-asserted-by":"crossref","unstructured":"Ibsen SD, Wright J, Lewis JM, Kim S, Ko S, Ong J, et al. Rapid Isolation and Detection of Exosomes and Associated Biomarkers from Plasma. ACS Nano. 2017; 11: 6641\u20136651.","DOI":"10.1021\/acsnano.7b00549"},{"key":"ref202","doi-asserted-by":"crossref","unstructured":"Samani NJ, Erdmann J, Hall AS, Hengstenberg C, Mangino M, Mayer B, et al. Genomewide Association Analysis of Coronary Artery Disease. New England Journal of Medicine. 2007; 357: 443\u2013453.","DOI":"10.1056\/NEJMoa072366"},{"key":"ref203","doi-asserted-by":"crossref","unstructured":"McPherson R, Pertsemlidis A, Kavaslar N, Stewart A, Roberts R, Cox DR, et al. A Common Allele on Chromosome 9 Associated with Coronary Heart Disease. Science. 2007; 316: 1488\u20131491.","DOI":"10.1126\/science.1142447"},{"key":"ref204","doi-asserted-by":"crossref","unstructured":"Haemmig S, Simion V, Yang D, Deng Y, Feinberg MW. Long noncoding RNAs in cardiovascular disease, diagnosis, and therapy. Current Opinion in Cardiology. 2017; 32: 776\u2013783.","DOI":"10.1097\/HCO.0000000000000454"},{"key":"ref205","unstructured":"Wang Y, Liang J, Xu J, Wang X, Zhang X, Wang W, et al. Circulating exosomes and exosomal lncRNA HIF1A-AS1 in atherosclerosis. International Journal of Clinical and Experimental Pathology. 2017; 10: 8383\u20138388."},{"key":"ref206","doi-asserted-by":"crossref","unstructured":"Chan K, Lu R, Chang J, Kan Y. NRF2, a member of the NFE2 family of transcription factors, is not essential for murine erythropoiesis, growth, and\u2009development. Proceedings of the National Academy of Sciences. 1996; 93: 13943\u201313948.","DOI":"10.1073\/pnas.93.24.13943"},{"key":"ref207","doi-asserted-by":"crossref","unstructured":"Ramos-Gomez M, Kwak MK, Dolan PM, Itoh K, Yamamoto M, Talalay P, et al. Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice. Proceedings of the National Academy of Sciences of the United States of America. 2001; 98: 3410\u20133415.","DOI":"10.1073\/pnas.051618798"},{"key":"ref208","doi-asserted-by":"crossref","unstructured":"Singh A, Misra V, Thimmulappa RK, Lee H, Ames S, Hoque MO, et al. Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer. PLoS Medicine. 2006; 3: e420.","DOI":"10.1371\/journal.pmed.0030420"}],"container-title":["Reviews in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.imrpress.com\/journal\/RCM\/23\/9\/10.31083\/j.rcm2309317","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T18:03:51Z","timestamp":1732730631000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.imrpress.com\/journal\/RCM\/23\/9\/10.31083\/j.rcm2309317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,14]]},"references-count":208,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022]]}},"alternative-id":["S1530-6550(22)00650-0"],"URL":"https:\/\/doi.org\/10.31083\/j.rcm2309317","relation":{},"ISSN":["1530-6550","2153-8174"],"issn-type":[{"value":"1530-6550","type":"print"},{"value":"2153-8174","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,14]]},"article-number":"317"}}